Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.17.21 extracted from

  • Kozikowski, A.P.; Nan, F.; Conti, P.; Zhang, J.; Ramadan, E.; Bzdega, T.; Wroblewska, B.; Neale, J.H.; Pshenichkin, S.; Wroblewski, J.T.
    Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase) (2001), J. Med. Chem., 44, 298-301.
    View publication on PubMed

Application

Application Comment Organism
medicine design of inhibitors may lead to effective neuroprotective agents, possibility to employ GCPII inhibitors in stroke therapy Rattus norvegicus

Inhibitors

Inhibitors Comment Organism Structure
(t-Bu)Cys-PSI[C-O]-Glu IC50: 29 nM Rattus norvegicus
2-(phosphonomethyl)pentanedioic acid IC50: 5.1 nM Rattus norvegicus
Asp-Glu
-
Rattus norvegicus
Asp-PSI[C-O-S]-Glu IC50: 0.0461 mM Rattus norvegicus
Asp-PSI[C-O]-Asp IC50: 0.0038 mM Rattus norvegicus
Asp-PSI[S]-Asp 0.1 mM, 42% inhibition Rattus norvegicus
Cys-PSI[C-O-S]-Glu IC50: 6.9 nM Rattus norvegicus
D-Glu-PSI[C-O]-D-Glu 0.1 mM, 67% inhibition Rattus norvegicus
D-Glu-PSI[C-O]-Glu 0.001 mM, 25% inhibition Rattus norvegicus
Glu-Glu
-
Rattus norvegicus
Glu-PSI[C-O-C-O]-Glu 0.001 mM, 9% inhibition Rattus norvegicus
Glu-PSI[C-O]-Glu IC50: 47 nM Rattus norvegicus
Gly-PSI[C-O-S]-Glu 0.001 mM, 46% inhibition Rattus norvegicus
t-BuNHC(O)-Glu 0.001 mM, 10% inhibition Rattus norvegicus
[HO2C(CH2)2CH(CO2H)CH2]2P(O)(OH)
-
Rattus norvegicus

Organism

Organism UniProt Comment Textmining
Rattus norvegicus
-
-
-

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0000051
-
IC50: 5.1 nM Rattus norvegicus 2-(phosphonomethyl)pentanedioic acid
0.0000069
-
IC50: 6.9 nM Rattus norvegicus Cys-PSI[C-O-S]-Glu
0.000029
-
IC50: 29 nM Rattus norvegicus (t-Bu)Cys-PSI[C-O]-Glu
0.000047
-
IC50: 47 nM Rattus norvegicus Glu-PSI[C-O]-Glu
0.0038
-
IC50: 0.0038 mM Rattus norvegicus Asp-PSI[C-O]-Asp
0.0461
-
IC50: 0.0461 mM Rattus norvegicus Asp-PSI[C-O-S]-Glu